KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Non-Current Deffered Revenue (2017 - 2019)

Guardant Health's Non-Current Deffered Revenue history spans 3 years, with the latest figure at $10.6 million for Q3 2019.

  • For Q3 2019, Non-Current Deffered Revenue rose 38.58% year-over-year to $10.6 million; the TTM value through Sep 2019 reached $10.6 million, up 38.58%, while the annual FY2018 figure was $7.8 million, 19.99% up from the prior year.
  • Non-Current Deffered Revenue for Q3 2019 was $10.6 million at Guardant Health, down from $10.9 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $10.9 million in Q2 2019 and bottomed at $6.5 million in Q4 2017.
  • The 3-year median for Non-Current Deffered Revenue is $8.4 million (2018), against an average of $8.7 million.
  • The largest annual shift saw Non-Current Deffered Revenue grew 19.99% in 2018 before it soared 38.58% in 2019.
  • A 3-year view of Non-Current Deffered Revenue shows it stood at $6.5 million in 2017, then increased by 19.99% to $7.8 million in 2018, then soared by 34.68% to $10.6 million in 2019.
  • Per Business Quant, the three most recent readings for GH's Non-Current Deffered Revenue are $10.6 million (Q3 2019), $10.9 million (Q2 2019), and $9.0 million (Q1 2019).